MAPT and breast carcinoma: In silico analyses have indicated that high expression of tau is associated with an increase in overall survival in patients with breast cancer, kidney clear cell carcinoma, and lung adenocarcinomas, but an inverse correlation has been reported for colon, head and neck cancer, and uterine cancer [22,43,64,65].